CG
PFE icon

Corundum Group’s Pfizer PFE Stock Holding History

Corundum Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$921K Buy
32,794
+357
+1% +$9.51K 0.31% 61
2025
Q4 		$808K Sell
32,437
-279
-0.9% -$7.04K 0.27% 60
2025
Q3 		$834K Buy
32,716
+541
+2% +$13.4K 0.34% 58
2025
Q2 		$780K Buy
32,175
+934
+3% +$21.8K 0.34% 59
2025
Q1 		$792K Buy
31,241
+17,439
+126% +$456K 0.38% 60
2024
Q4 		$366K Sell
13,802
-28,939
-68% -$785K 0.14% 80
2024
Q3 		$1.24M Sell
42,741
-10,820
-20% -$316K 0.56% 40
2024
Q2 		$1.5M Buy
53,561
+12,725
+31% +$350K 0.59% 46
2024
Q1 		$1.13M Buy
40,836
+18,153
+80% +$504K 0.55% 43
2023
Q4 		$653K Sell
22,683
-14,133
-38% -$427K 0.33% 62
2023
Q3 		$1.22M Sell
36,816
-222
-0.6% -$7.85K 0.69% 29
2023
Q2 		$1.36M Sell
37,038
-5,246
-12% -$204K 0.68% 32
2023
Q1 		$1.73M Buy
42,284
+12,113
+40% +$523K 0.82% 29
2022
Q4 		$1.55M Buy
30,171
+666
+2% +$31.9K 0.87% 30
2022
Q3 		$1.29M Buy
29,505
+774
+3% +$37.6K 0.81% 29
2022
Q2 		$1.51M Buy
28,731
+1,664
+6% +$84.8K 1.02% 22
2022
Q1 		$1.4M Buy
27,067
+5,531
+26% +$287K 1.3% 22
2021
Q4 		$1.27M Buy
21,536
+2,174
+11% +$108K 0.83% 20
2021
Q3 		$833K Buy
19,362
+777
+4% +$34.4K 0.62% 27
2021
Q2 		$728K Buy
18,585
+967
+5% +$37.6K 0.48% 30
2021
Q1 		$638K Buy
17,618
+435
+3% +$15.4K 0.5% 31
2020
Q4 		$633K Sell
17,183
-405
-2% -$14.9K 0.53% 28
2020
Q3 		$612K Buy
17,588
+776
+5% +$27.2K 0.59% 24
2020
Q2 		$522K Sell
16,812
-467
-3% -$15.9K 0.63% 20
2020
Q1 		$535K Sell
17,279
-104
-0.6% -$3.54K 0.76% 19
2019
Q4 		$646K Buy
17,383
+301
+2% +$10.7K 0.68% 19
2019
Q3 		$582K Sell
17,082
-5
-0% -$182 0.67% 19
2019
Q2 		$702K Buy
17,087
+856
+5% +$34K 0.81% 17
2019
Q1 		$654K Sell
16,231
-10,344
-39% -$414K 0.75% 17
2018
Q4 		$1.1M Buy
+26,575
New +$1.1M 1.01% 16
2018
Q2 		$542K Buy
15,736
+91
+0.6% +$3.11K 0.67% 18
2018
Q1 		$527K Buy
15,645
+335
+2% +$11.5K 0.57% 17
2017
Q4 		$526K Buy
15,310
+8
+0.1% +$273 0.57% 20
2017
Q3 		$518 Buy
15,302
+1,544
+11% +$49.6K 0.55% 18
2017
Q2 		$438K Buy
13,758
+1,004
+8% +$31.7K 0.97% 13
2017
Q1 		$414K Hold
12,754
– – 0.52% 15
2016
Q4 		$393K Hold
12,754
– – 0.58% 14
2016
Q3 		$410K Sell
12,754
-211
-2% -$7.05K 0.66% 14
2016
Q2 		$433K Sell
12,965
-261
-2% -$8.33K 0.67% 12
2016
Q1 		$372K Sell
13,226
-234
-2% -$6.68K 0.98% 14
2015
Q4 		$389K Buy
13,460
+1,432
+12% +$45K 1.16% 9
2015
Q3 		$358K Buy
+12,028
New +$386K 1.27% 8

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Corundum Group's PFE Position: Q1 2026 in Review

Corundum Group increased its Pfizer (PFE) stake by 1.1% in Q1 2026, buying an estimated $9.51K and bringing the position to 32,794 shares worth $921K. The position accounts for 0.31% of the portfolio, ranked #61.

Corundum Group first reported a position in PFE in Q3 2015 and has held it in 42 quarters since. The position peaked at $1.73M in Q1 2023. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Corundum Group held 32,794 shares of Pfizer worth $921K as of Q1 2026.
  • Corundum Group bought 357 Pfizer shares in Q1 2026, an estimated $9.51K.
  • Pfizer made up 0.31% of Corundum Group's portfolio in Q1 2026, its #61 holding.
  • Corundum Group first reported a position in Pfizer in Q3 2015 and has held it in 42 quarters since.
  • Corundum Group's Pfizer position peaked at $1.73M in Q1 2023.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Corundum Group's 13F filing for Q1 2026, filed 20 Apr 2026.